|
SMMT Summit Therapeutics Inc 1599298 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-189,424,000.00 |
| Balance Sheet |
|
Current Assets
|
$616,598,000.00 |
|
Assets
|
$647,856,000.00 |
|
Current Liabilities
|
$83,266,000.00 |
|
Liabilities
|
$101,924,000.00 |
|
Equity
|
$545,932,000.00 |
|
Shares Out
|
776017474.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-122,291,000.00 |
|
Investing Cash Flow
|
$-238,000.00 |
| Market Analysis |
Market Cap
|
$10,429,674,850.56 |
|
Price
|
$12.89 |
|
BVPS
|
0.70 |
|
PB
|
19.20 |
|
EPS
|
-0.24 |
|
FCF
|
$-122,536,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:16 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:10 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-23 |
-0.14 |
|
| Apr |
May |
Jun |
|
|
2026-04-30 |
-0.15 |
|
|
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-11 |
-0.12 |
|
| Oct |
Nov |
Dec |
|
|
2025-10-20 |
-0.13 |
|
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view SMMT documents filed with the SEC.
SMMT Filings
Clear
